Store in a dark section of your refrigerator or wrap the vial in foil
The 4 mg dose produced 11% weight loss, still clinically meaningful but notably lower than the maximum dose
Nausea commonly persists 2448 hours post-injection during the first one or two doses at 4 mg [1]
This post explores how retatrutide works, its impact on metabolic processes, and what this means for those seeking better weight loss outcomes
5-12 The most common patient-reported adverse effects (AEs) associated with GLP-1 RAs and dual GIP/GLP-1 RAs are gastrointestinal (GI) in nature and may include abdominal pain, constipation, diarrhea, nausea, and vomiting
Xerostomia is diagnosed according to signs and symptoms of oral dryness rather than by any quantitative or qualitative analyses of saliva